|Bid||1.2700 x 800|
|Ask||0.0000 x 1100|
|Day's Range||1.3700 - 1.4800|
|52 Week Range||0.5400 - 1.4900|
|Beta (3Y Monthly)||0.69|
|PE Ratio (TTM)||139.00|
|Earnings Date||Nov. 15, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Unless you borrow money to invest, the potential losses are limited. But if you pick the right business to buy shares...
Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $978 thousand in the third quarter of 2019, compared to an operating loss for the same period last year of $60 thousand, and that overall unit sales for the third quarter of 2019 increased 15.8% over same period in the prior year. Domestic revenues increased 3.3%. The domestic product mix may be more heavily weighted to syringes.
If you want to know who really controls Retractable Technologies, Inc. (NYSEMKT:RVP), then you'll have to look at the...
Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $12,000.00 and $42,800.00, respectively. The dividend amount is $0.125 per share for Series I Class B shareholders and $0.25 per share for Series II Class B shareholders.
Retractable Technologies, Inc. (NYSE American: RVP) reports the following results of operations for the three months ended March 31, 2019 as compared to results for the same period in the prior year. Domestic revenues decreased 6.9% principally due to lower volumes and lower average selling prices. Domestic unit sales decreased 0.9%.
Retractable Technologies, Inc. (NYSE American: RVP) reports that a settlement has been reached with both Becton, Dickinson and Company (“BD”) and MDC Investment Holdings, Inc. (“MDC”) to settle all existing litigation by and against Retractable. A settlement agreement, effective May 3, 2019, released all claims by Retractable against BD and MDC arising prior to May 3, 2019 and all claims by BD and MDC against Retractable arising prior to May 3, 2019.
Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that on March 26, 2019, the Fifth Circuit Court of Appeals affirmed the district court’s finding which had determined that neither disgorgement of profits nor further injunctive relief should be granted to Retractable in its case against Becton, Dickinson and Company (“BD”), despite finding that BD falsely advertised its products for years. Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle.